戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ars (range, 0.5 to 5.4) and all have died of small-cell cancer.
2 ears ( 7.7); 60% were female and 80% had non-small cell cancer, 50% had advanced stage, and 55% had W
3  32(median, 9.1 ng/mL), the seven (58%) with small cell cancer and bone metastases had an average PSA
4                                          Non-small-cell cancer cell line A549 revealed dose-dependent
5 res on the adenocarcinoma cell line A549 and small-cell cancer cell lines H345, N417, and H510.
6                     The mean size of the non-small cell cancers detected at CT was 15.0 mm.
7               Twenty-one (60%) of the 35 non-small cell cancers detected at CT were stage IA at diagn
8                     The mean size of the non-small cell cancers detected by computed tomography was 1
9                   Twelve (57%) of the 21 non-small cell cancers detected by computed tomography were
10  than 50% shift in proportion of stage I non-small cell cancer detection did not show statistical sig
11 g cancer (SCLC) cell lines, 3 extrapulmonary small cell cancer (ExPuSC) cell lines, and 691 resected
12 ly increased in humans with unresectable non-small cell cancer of the lung, and this increase is dram
13  prostate cancer, including 12 patients with small cell cancer of the prostate, underwent CT before p
14  in whom weakness heralded the presence of a small-cell cancer of the lung.
15 ort: A 57-year-old male, with a diagnosis of small-cell cancer of the right lung (microcellular anapl
16     Surgical resection for stage I or II non-small cell cancer remains the only reliable treatment fo
17 dian, 4 ng/ml), with a mean PSA level in the small cell cancer subgroup of 12.3 ng/ml +/- 9.0 (range,
18 /mL +/- 7.9 (median, 1.6 ng/mL); that in the small cell cancer subgroup was only 2.8 ng/ml +/- 1.4 (m
19                         In patients with non-small-cell cancer, surgical resection offers substantial
20         Twenty-eight subsequent cases of non-small cell cancers were detected, of which 17 (61%; 95%
21 iously untreated patients with limited-stage small-cell cancer were treated with etoposide/cisplatin
22 CLC, four mesotheliomas, five extrapulmonary small cell cancers) were analysed for PTEN/MMAC1 homozyg